Affimed Reports Efficacy, Safety Data From Leukemia Treatment Study-February 2024-www.financetom.com

Affimed Reports Efficacy, Safety Data From Leukemia Treatment Study

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Affimed Reports Efficacy, Safety Data From Leukemia Treatment Study

Dec 9, 2024 11:29 AM

02:02 PM EST, 12/09/2024 (MT Newswires) -- Affimed ( AFMD ) said Monday that AFM28 showed "promising" efficacy and safety results evaluating the drug candidate in patients with relapsed/refractory acute myeloid leukemia in an ongoing phase 1 study.

The drug candidate reached a 40% composite complete remission rate at the highest dose level of 300 milligrams in heavily pretreated patients, the company said.

The company said AFM28 showed a "favorable" safety profile, with no signs of neurotoxicity or immune-related side effects seen.

Affimed ( AFMD ) said the assessment of higher dose levels is being planned, based on the safety profile and the likely dose-effect relationship.

Price: 2.27, Change: -0.06, Percent Change: -2.58

Previous page： J B Hunt Transport Services Insider Sold Shares Worth $303,018, According to a Recent SEC Filing Next page： Symbotic Insider Sold Shares Worth $660,933, According to a Recent SEC Filing

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

J B Hunt Transport Services Insider Sold Shares Worth $303,018, According to a Recent SEC Filing

Nov 9, 2024

05:42 PM EST, 11/06/2024 (MT Newswires) -- Ronald Greer Woodruff, Executive Vice President, Safety, ESG, Maintenance, on November 06, 2024, sold 1,583 shares in J B Hunt Transport Services ( JBHT ) for $303,018. Following the Form 4 filing with the SEC, Woodruff has control over a total of 18,262 shares of the company, with 18,262 shares held directly. SEC...

Symbotic Insider Sold Shares Worth $660,933, According to a Recent SEC Filing

Nov 9, 2024

05:41 PM EST, 11/06/2024 (MT Newswires) -- Carol J. Hibbard, Chief Financial Officer, on November 03, 2024, sold 22,821 shares in Symbotic ( SYM ) for $660,933. Following the Form 4 filing with the SEC, Hibbard has control over a total of 34,188 shares of the company, with 34,188 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1837240/000183724024000205/xslF345X05/wk-form4_1730932672.xml Price: 28.40, Change: -0.04, Percent...

Host Hotels forecasts lower 2024 FFO on weak US demand, slow Maui recovery

Nov 9, 2024

Nov 6 (Reuters) - Real estate investment trust Host Hotels & Resorts ( HST ) cut its forecast for 2024 adjusted funds from operations on Wednesday, weighed down by weak U.S. leisure travel demand and a slow recovery in Maui. Demand for leisure travel in the United States was weak during the third quarter, hurting companies like Host, whose property...

Steris beats quarterly estimates on continued demand for medical procedures

Nov 9, 2024

Nov 6 (Reuters) - Medical equipment maker Steris ( STE ) beat second-quarter profit estimates on Wednesday, on continued demand for non-urgent medical procedures that boosted sales of its surgical and examination tools. The company has seen strong sales for the last few quarters due to sustained demand for healthcare services. Steris ( STE ) continues to expect its fiscal...